Compositions and methods for treating neurosynaptic disorder in a subject
are described. More specifically, compositions and methods for inhibiting glutamate
uptake by synaptic vesicles in a subject are set forth. In one embodiment, the
composition is inhibitory protein factor (IPF) and the subject is a human.